Vijay Ranganath Baichwal
Hearing Aid Provider in Salt Lake City, UT
License number
Utah 6885319-8914
Issued Date
Feb 28, 2008
Expiration Date
Sep 30, 2013
Category
xControlled Substance Handler
Type
Controlled Substance Handler Individual
Address
Address
Salt Lake City, UT
Personal information
See more information about Vijay Ranganath Baichwal at radaris.comName
Address
Phone
339 E 600 S APT 1404, Salt Lake City, UT 84111
339 E 600 S #1404, Salt Lake City, UT 84111
Professional information
See more information about Vijay Ranganath Baichwal at trustoria.com
Compounds And Therapeutical Use Thereof
Compounds And Therapeutical Use Thereof
US Patent:
2008003, Feb 7, 2008
Filed:
Jul 17, 2007
Appl. No.:
11/779086
Inventors:
Sui Xiong Cai - San Diego CA, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
Cytovia, Inc. - San Diego CA
Cytovia, Inc. - San Diego CA
International Classification:
A61K 31/517, A61K 31/52, A61K 31/5377, A61P 31/10, A61P 35/00, C07D 239/94, C07D 401/12, C07D 413/12, C07D 473/16
US Classification:
514234500, 514263400, 514266210, 514266400, 544119000, 544277000, 544284000, 544293000
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Compounds And Therapeutical Use Thereof
Compounds And Therapeutical Use Thereof
US Patent:
2008003, Feb 14, 2008
Filed:
Jul 23, 2007
Appl. No.:
11/781660
Inventors:
Sui Cai - San Diego CA, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
Cytovia, Inc. - San Diego CA
Cytovia, Inc. - San Diego CA
International Classification:
A61K 31/517, A61P 35/00, C07D 239/72
US Classification:
514266100, 544283000
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Compounds And Therapeutical Use Thereof
Compounds And Therapeutical Use Thereof
US Patent:
2005013, Jun 23, 2005
Filed:
Jul 6, 2004
Appl. No.:
10/885903
Inventors:
Sui Cai - San Diego CA, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K031/519, A61K031/517
US Classification:
514262100, 514264110, 514266400
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Compounds And Therapeutical Use Thereof
Compounds And Therapeutical Use Thereof
US Patent:
2007020, Sep 6, 2007
Filed:
Jan 5, 2007
Appl. No.:
11/620498
Inventors:
Sui Cai - San Diego CA, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K 31/517, C07D 403/02, C07D 239/94
US Classification:
514266200, 514266300, 514266400, 544284000, 544286000, 544293000
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Compounds And Therapeutical Use Thereof
Compounds And Therapeutical Use Thereof
US Patent:
2007024, Oct 18, 2007
Filed:
Mar 1, 2007
Appl. No.:
11/680843
Inventors:
Sui Cai - San Diego CA, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
Cytovia, Inc - San Diego CA
Cytovia, Inc - San Diego CA
International Classification:
A61K 31/517, A61K 31/5355, C07D 239/94, C07D 401/12, C07D 413/12, C07D 473/00
US Classification:
514233800, 514264110, 514266200, 514266210, 514266230, 514266240, 514266300, 514266400, 544119000, 544264000, 544284000, 544293000
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Compounds And Therapeutical Use Thereof
Compounds And Therapeutical Use Thereof
US Patent:
2007024, Oct 18, 2007
Filed:
Mar 13, 2007
Appl. No.:
11/685342
Inventors:
Sui Cai - San Diego CA, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
Cytovia, Inc. - San Diego CA
Cytovia, Inc. - San Diego CA
International Classification:
A61K 31/517, A61K 31/5355, C07D 239/94, C07D 401/12, C07D 413/12, C07D 473/00
US Classification:
514233800, 514264110, 514266200, 514266210, 514266230, 514266240, 514266300, 514266400, 544119000, 544264000, 544284000, 544293000
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Compounds And Therapeutical Use Thereof
Compounds And Therapeutical Use Thereof
US Patent:
2007024, Oct 25, 2007
Filed:
Mar 29, 2007
Appl. No.:
11/693432
Inventors:
Sui Cai - San Diego CA, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Nilantha Sirisoma - San Diego CA, US
Azra Pervin - Escondido CA, US
John Drewe - Carlsbad CA, US
Shailaja Kasibhatla - San Diego CA, US
Songchun Jiang - San Diego CA, US
Hong Zhang - San Diego CA, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
John Manfredi - Salt Lake City UT, US
Leena Bhoite - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
Cytovia, Inc. - San Diego CA
Cytovia, Inc. - San Diego CA
International Classification:
A61K 31/47, A61K 31/50, A61K 31/517, A61K 31/52, A61K 31/535, A61P 31/00
US Classification:
514234800, 514252020, 514255050, 514263100, 514266100, 514266200, 514311000, 544116000, 544238000, 544258000, 544264000, 544284000, 544293000, 546159000
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Method Of Treating Cancer
Method Of Treating Cancer
US Patent:
2008004, Feb 21, 2008
Filed:
Jun 27, 2007
Appl. No.:
11/769322
Inventors:
Bruce Roth - Salt Lake City UT, US
Vijay Baichwal - Salt Lake City UT, US
Chris Pleiman - Holladay UT, US
Vijay Baichwal - Salt Lake City UT, US
Chris Pleiman - Holladay UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K 31/195, A61P 35/00
US Classification:
514563000
Abstract:
The present invention provides therapeutic compounds and methods for the treatment of refractory and multidrug resistant cancers in patients in need of such treatment.